LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Corporate  :  Suven Life Sciences secures two product patents in Macau and New Zealand

Suven Life Sciences secures two product patents in Macau and New Zealand (01-Aug-2016)

Suven Life Sciences (Suven) has been granted one product patent from Macau and one product patent from New Zealand corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032.

The granted claims of the patents are from the mechanism of action include the class of selective 5-HT4 compounds and H3 Inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven has a total of nine granted patents from Macau and twenty five granted patents from New Zealand. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.




Top News Today
Reliance Nippon Life Insurance's total premium rises to Rs 4,042 crore in FY18
(23-Apr-2018)

Reliance Nippon Life InsuranceReliance Capital's subsidiary -- Reliance Nippon Life Insurance Company has reported a the total premium of Rs 4,042 crore ($622 million) in FY18. The renewal premium rose to Rs 3,154 crore ($485......click on news to read complete article.

Gujarat Ambuja Exports starts commercial operations of first phase of green field plant
(23-Apr-2018)

Gujarat Ambuja Exports starts commercial operations of first phase of green field plantGujarat Ambuja Exports has commenced the commercial operations of first phase of its 1000 MT per day green field Maize processing plant set up at Chalisgaon in Maharashtra. This marks the completion of......click on news to read complete article.

KPIT partners with Indian Government to support first Smart India Hackathon 2018
(23-Apr-2018)

KPIT partners with Indian Government to support first Smart India Hackathon 2018KPIT Technologies has partnered with the Indian Government to support the first Smart India Hackathon 2018 - Hardware Edition. KPIT, which brings expertise in developing clean, green and intelligent technologies......click on news to read complete article.

International Stock News
Asian markets trade mostly in red in early deals on Monday
(23-Apr-2018)

Asian markets trade mostly in red in early deals on MondayMost of the Asian equity indices are trading lower in the early deals on Monday, following the negative lead from Wall Street on Friday as technology stocks declined. Investors are cautious as they kept......click on news to read complete article.

US markets closed lower on Friday
(21-Apr-2018)

US markets closed lower on FridayThe US markets closed lower on Friday, as weakness in technology and consumer staples shares offset the latest batch of corporate earnings, which largely continued to beat expectations. The selling pressure......click on news to read complete article.

US markets closed lower on Friday
(21-Apr-2018)

US markets closed lower on FridayThe US markets closed lower on Friday, as weakness in technology and consumer staples shares offset the latest batch of corporate earnings, which largely continued to beat expectations. The selling pressure......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.